Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Dermatol Surg ; 49(6): 566-569, 2023 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-36946689

RESUMO

BACKGROUND: Perioral rhytides can be treated with laser and energy-based devices. More recently, a novel fractional thermomechanical skin rejuvenation system was developed to cause controlled thermal injury through direct heat transfer. OBJECTIVE: A prospective clinical trial evaluated the safety and efficacy of a thermomechanical fractional injury device (Tixel 2, Novoxel, Netanya, Israel) for perioral rhytides. MATERIALS AND METHODS: Subjects with moderate-to-severe perioral rhytides were enrolled and underwent 4 monthly treatments. RESULTS: Twenty-three subjects were enrolled and completed all study visits. Mean age was 62.5 years, and 100.0% were women. Fitzpatrick Skin Types I-IV were included. For Fitzpatrick Wrinkle Classification System (FWCS), mean baseline score was 6.9. Per investigator, there was a mean 1.9-grade improvement in FWCS at 3-month follow-up ( p < .0001). At 3-month follow-up, 8.7% (n = 2) of subjects had a 3-grade improvement, 69.6% (n = 16) had a 2-grade improvement, and 21.7% (n = 5) had a 1-grade improvement. For physician Global Aesthetics Improvement Scale at 3-month follow-up, 69.6% (n = 16) had 76% to 100% improvement, 13.0% (n = 3) had 51% to 75% improvement, and 17.4% (n = 4) had 26% to 50% improvement. There were no severe adverse events, and subjects experienced minimal pain. CONCLUSION: A novel device using thermomechanical fractional injury was demonstrated to be safe and effective in the treatment of perioral rhytides.


Assuntos
Técnicas Cosméticas , Envelhecimento da Pele , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Técnicas Cosméticas/efeitos adversos , Dor/etiologia , Rejuvenescimento , Pele , Resultado do Tratamento , Estudos Prospectivos
2.
Dermatol Surg ; 49(4): 374-377, 2023 04 01.
Artigo em Inglês | MEDLINE | ID: mdl-36826343

RESUMO

BACKGROUND: Periorbital rejuvenation is a common cosmetic concern. A fractional thermomechanical skin rejuvenation system was developed to offer clinical improvements from direct heat transfer. OBJECTIVE: A prospective study evaluated the efficacy and safety of the device for periorbital fine lines and wrinkles. MATERIALS AND METHODS: Subjects with moderate-to-severe periorbital rhytides were enrolled and underwent 4 monthly treatments with a novel device using thermomechanical fractional injury (Tixel 2; Novoxel, Netanya, Israel). RESULTS: Fifty-one subjects were enrolled. Mean age was 56.8 years, and 88.2% were women. Fitzpatrick skin Types I to IV were included. For Fitzpatrick Wrinkle Classification System (FWCS), mean baseline score was 5.7. Per investigator, there was a mean 2.0-grade improvement in FWCS at 3-month follow-up ( p < .0001). Per 3 blinded physician raters, there was a mean improvement of 2.2 ( p < .0001), 2.0 ( p < .0001), and 1.2 ( p < .0001) in FWCS at 3-month follow-up. Each of the raters correctly identified posttreatment images for 87.5%, 77.1%, and 75.0% of subjects. At least 2 raters agreed on grading 83.3% of subjects as responders. There were no severe adverse events. Subjects experienced minimal pain and downtime. CONCLUSION: A novel device using thermomechanical fractional injury was demonstrated to be safe and effective in the treatment of periorbital rhytides.


Assuntos
Técnicas Cosméticas , Envelhecimento da Pele , Humanos , Feminino , Pessoa de Meia-Idade , Masculino , Estudos Prospectivos , Face , Pele , Técnicas Cosméticas/efeitos adversos , Dor/etiologia , Rejuvenescimento , Resultado do Tratamento
3.
J Drugs Dermatol ; 17(5): 499-505, 2018 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-29742179

RESUMO

BACKGROUND: An increase in nonmelanoma skin cancer (NMSC) in younger patients has been reported. Many are treated with Mohs micrographic surgery (MMS). OBJECTIVE: Investigate patient and tumor characteristics in patients less than 50 years undergoing MMS for NMSC at a large, referral-based practice. METHODS & MATERIALS: Retrospective chart review of 1,332 tumors occurring in 1,018 consecutive patients over a five-year period. RESULTS: 81.7% of tumors were BCC and 55.3% occurred in women. Patients less than 30 years were more likely to be female (P equals 0.016) and women were more likely to have BCC (P equals 0.010). SCCs were more likely with increasing age (P less than 0.001). Of all tumors, 3.6% were recurrent, 2.7% had diameters ≥ 2 centimeters, and 5.5% of all BCCs had a high-risk histologic subtype. Women were more than twice as likely as men to be referred to plastic surgery for repair (P equals 0.020). CONCLUSION: Patients < 50 years with NMSC may represent a growing population referred for MMS, especially young women with BCC. High-risk tumor features were rare among young patients, and female gender was associated with an increased rate of referral for repair by a plastics subspecialty. Study was performed at the Laser & Skin Surgery Center of New York. IRB STATUS: Approved by Essex Institutional Review Board, Protocol #MOHS40-65

J Drugs Dermatol. 2018;17(5):499-505.

.


Assuntos
Carcinoma Basocelular/epidemiologia , Carcinoma de Células Escamosas/epidemiologia , Neoplasias Cutâneas/epidemiologia , Adulto , Fatores Etários , Carcinoma Basocelular/etiologia , Carcinoma Basocelular/cirurgia , Carcinoma de Células Escamosas/etiologia , Carcinoma de Células Escamosas/cirurgia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Cirurgia de Mohs , New York/epidemiologia , Encaminhamento e Consulta , Estudos Retrospectivos , Fatores Sexuais , Neoplasias Cutâneas/etiologia , Neoplasias Cutâneas/cirurgia , Adulto Jovem
4.
J Drugs Dermatol ; 15(11): 1420-1426, 2016 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-28095557

RESUMO

BACKGROUND: Photodynamic therapy (PDT) is an FDA approved treatment for actinic keratoses (AK's) although multiple off-label indi- cations are reported. Despite frequent use for AK's, no clear consensus exists regarding protocols for overall treatment parameters. METHODS: Retrospective chart review of 1,491 subjects who underwent PDT between 2007 and 2011 at a high volume laser surgery center. Demographic information, clinical history, treatment data, and subsequent diagnosis of skin cancers were recorded. An ex- ploratory subgroup analysis was performed for patients treated for AK and/or squamous cell carcinoma (SCC) that developed SCC or remained SCC-free one year after treatment. RESULTS: The most common indications for PDT were actinic keratoses (n=1404, 94.9%) then NMSC (n=45, 3.0%) The most common treatment site was the head and neck (n=1274, 86.1%). Blue light activation (405-420nm) was used more frequently than red light and visible light. (73.8% vs. 22.8% vs. 6.8%). The most commonly used photosensitizer was aminolevulinic acid (ALA) (98.6%, n=1456). Topical application (97.7% n=1437) of photosensitizer was used more frequently than intralesional administration (2.0%, n=29). 580 patients met subgroup analysis criteria. 66 developed SCC at treatment site (11%). Factors associated with developing SCC were older age, SCC history, Fitzpatrick skin-type 1, and sixty-minute or less incubation times (P less than 0.05 for all factors). The SCC subgroup had a unique distribution of treatment sites (P less than.001). No statistically significant differences were observed for gender or wavelength. CONCLUSION: There are differences in protocols based on indication and location of lesion. Blue light is preferable for superFIcial lesions and red light for deeper lesions. Intralesional delivery is used more commonly for NMSC. Extremities require longer incubation times. PDT may be more effective with younger patients and longer than sixty-minute incubation times. PDT chemoprevention is independent of light source used. J Drugs Dermatol. 2016;15(11):1420-1426..


Assuntos
Procedimentos Cirúrgicos Dermatológicos/métodos , Ceratose Actínica/cirurgia , Terapia a Laser/métodos , Fotoquimioterapia/métodos , Neoplasias Cutâneas/cirurgia , Idoso , Idoso de 80 Anos ou mais , Estudos de Coortes , Procedimentos Cirúrgicos Dermatológicos/tendências , Feminino , Humanos , Ceratose Actínica/diagnóstico , Ceratose Actínica/epidemiologia , Terapia a Laser/tendências , Masculino , Pessoa de Meia-Idade , Fotoquimioterapia/tendências , Estudos Retrospectivos , Neoplasias Cutâneas/diagnóstico , Neoplasias Cutâneas/epidemiologia
5.
Clin Dermatol ; 42(4): 360-372, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38336142

RESUMO

Growth in the research, innovation, and development of laser and energy-based technologies over the past few decades has led to dramatic increases in treatment options for dermatologic and cosmetic concerns of the periorbital area. We highlight recent treatment options using laser and energy-based devices for the clearance of periocular pigmented lesions, including solar lentigines and nevus of Ota; vascular lesions, including port-wine birthmarks, infantile hemangiomas, superficial telangiectasias, and reticular veins; laser ablation of benign tumors, such as xanthelasma; cosmetic rejuvenation; treatment of infraorbital dark circles and festoons; laser removal of eyebrow and eyeliner tattoos; and device-based treatment of chronic dry eyes.


Assuntos
Terapia a Laser , Humanos , Rejuvenescimento , Tatuagem , Técnicas Cosméticas/instrumentação , Neoplasias Cutâneas/terapia , Neoplasias Cutâneas/cirurgia , Lentigo/terapia , Telangiectasia/terapia , Hemangioma/terapia
6.
J Clin Aesthet Dermatol ; 16(11): 47-49, 2023 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-38076654

RESUMO

Background: Cosmetic tattoos in the periocular area, including microblading, have become increasingly popular. More patients have been seeking laser tattoo removal.OBJECTIVE: A retrospective chart review for the laser treatment of eyeliner and eyebrow tattoos and a discussion of treatment experiences can better inform physicians. Methods: A retrospective chart review was performed over five years with patients who had eyeliner and/or eyebrow tattoos and had laser removal. Results: Overall, 76 patients were treated. Mean age was 47 years, and 98.7 percent were women. Fitzpatrick Skin Types I-VI were represented. Of all cases, 55.3 percent included eyebrows, 43.4 percent eyelids, and 1.3 percent both. There was a mean of 2.8 treatments. Common colors included black (73.7%), black/red (7.9%), black/orange (5.3%), black/yellow (3.9%), and red (3.9%). Most cases were treated with 755nm picosecond laser or high peak-powered 532nm/1064nm picosecond laser. After initial treatment, 26.3 percent of cases involved unmasking of colors, such as red, orange, yellow, green, and blue, which were not previously visualized. There were no documented adverse events related to scarring, hypotrichosis, necrosis, and burns. Conclusion: Laser removal of eyeliner and eyebrow tattoos can be safe and effective. There should be consideration for eye and hair protection, pain control, and pigment unmasking.

7.
Adv Ther ; 39(9): 4021-4036, 2022 09.
Artigo em Inglês | MEDLINE | ID: mdl-35870104

RESUMO

Platelet-rich plasma (PRP) has gained tremendous traction for a broad variety of indications within regenerative medicine. Despite a lack of standardized literature assessing efficacy and best practice procedures for preparation, PRP has become increasingly utilized for cutaneous rejuvenation. In this review, we highlight the many variations that may affect the quality and effectiveness of PRP, while also outlining the highest quality evidence that exists for facial rejuvenation. In reviewing the use of PRP for this indication, most high-quality evidence suggests subtle to modest clinical improvement, with many studies demonstrating conflicting results. Additional high-quality investigative work with clearly delineated methodologies is needed in order to better understand the role of PRP.


Assuntos
Técnicas Cosméticas , Plasma Rico em Plaquetas , Envelhecimento , Face , Humanos , Rejuvenescimento
8.
Clin Dermatol ; 40(1): 11-18, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35190059

RESUMO

A port-wine stain (PWS) is a vascular birthmark present in 0.3% to 0.5% of newborns. If untreated, this erythematous patch will grow proportionally with the child to thicken and darken with age. PWSs have implications for the child's quality of life for many years, with cosmetic, medical, and psychosocial disability. Controversy exists in many aspects surrounding laser treatment of these birthmarks in the pediatric population. We have reviewed the clinical features as well as the historic and current laser treatment of PWS. We have also examined the current hot topics of debate surrounding the treatment of PWS in the pediatric population. These controversies include the patient age of treatment initiation, the long-term psychologic impact, the use of general anesthesia, the application of eye shields, and alternative treatments for recalcitrant PWS. We have concluded with a discussion on the future directions of management and treatment.


Assuntos
Hemangioma Capilar , Mancha Vinho do Porto , Criança , Estética , Humanos , Recém-Nascido , Mancha Vinho do Porto/psicologia , Mancha Vinho do Porto/terapia , Qualidade de Vida , Resultado do Tratamento
10.
Int J Infect Dis ; 29: 178-80, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25449255

RESUMO

The cutaneous ulcer in a patient with a history of international travel poses a vexing diagnostic dilemma for the clinician. While Streptococcus and Staphylococcus are common causes of cutaneous ecthyma, the necrotizing ulcer can have a vast differential diagnosis including ulcerating zoonoses.


Assuntos
Ectima/diagnóstico , Viagem , Idoso , Animais , Diagnóstico Diferencial , Ectima/patologia , Humanos , Masculino , Zoonoses/diagnóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA